NEW YORK (GenomeWeb) – Genomic Vision reported today that its full-year 2015 revenues fell 12 percent from 2014.

The French molecular diagnostics company said total revenues fell to €4.3 million ($4.8 million) from €4.9 million in 2014. Product sales rose 23 percent to €291,000 from €237,000 the year before, but the gain was offset by a 34 percent fall in revenues from the company's R&D collaboration with Quest Diagnostics to €2.1 million from €3.2 million in 2014. The firm said the decrease was expected as milestone payments attached to the deal were ending.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.